Clinical trial · Observational
CWI and Discharge After Breast Cancer Surgery
Continuous Wound Infiltration and 23 Hour Discharge Following Major Breast Cancer Surgery
NCT02897934CI-TRIAL-00049789completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objectives of this work are threefold: 1. To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery 2. To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care 3. To evaluate patient satisfaction with their care pathway
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bupivacaine continuous infusion | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Pain
- timeFrame
- 24 hours, 48 hours
- description
- Pain will be recorded at at 24 and 48 hours using a slide-rule page on bespoke Android App. Pain will be recorded in a manner analogous to a visual analog scale 0 = No pain, 100 = Worst imaginable pain. Participants will be prompted on the first and second postoperative days to score their worst level of pain.
Secondary outcomes (4)
- measure
- Quality of recovery at 24 & 48 hours (QoR 40)
- timeFrame
- 24 hours, 48 hours
- description
- The quality of postoperative recovery from surgery and anaesthesia will be scored on the first and second postoperative day using the validated QoR 40 score. These metrics will be recorded on a bespoke Android App.
- measure
- Analgesic Consumption at 24 & 48 hours
- timeFrame
- 24 hours, 48 hours
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: Women undergoing any one of: mastectomy mastectomy with axillary lymph node clearance mastectomy with axillary lymph node sampling Exclusion Criteria: Refusal to participate; Allergy to Bupivacaine; Pre-existing pain conditions; Regular use of opioid analgesia; Pregnancy; Uncontrolled Diabetes; Uncontrolled Thyroid disorder; Severe cardiac, renal or hepatic disease ; Bilateral surgery; Planned discharge \>23 hours; Travel time from the admitting hospital \>45 minutes; Absence of intellectual capacity to consent
References
Publications (0)
Data not yet available
No reference posted for this study.